Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lübbert

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
Oncogene|October 26, 2005
ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETOJ Lausen, S Liu, M Fliegauf, et al.
Oncogene|July 8, 2008
Complementing mutations in core binding factor leukemias: from mouse models to clinical applicationsA M S Müller, J Duque, J A Shizuru, et al.
Annals of Hematology|October 8, 2005
An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patientsP W Wijermans, M Lübbert, G Verhoef, et al.
Leukemia & Lymphoma|December 31, 1997
Successful treatment of disseminated central nervous aspergillosis in a patient with acute myeloblastic leukemiaU Mahlknecht, F von Lintig, R Mertelsmann, et al.
Leukemia|July 30, 2003
Absence of somatic mutations within the Runt domain of AML2/RUNX3 in acute myeloid leukaemiaF Otto, M Stock, M Fliegauf, et al.
Leukemia|October 29, 2004
Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanismsK Schmelz, N Sattler, M Wagner, et al.
Leukemia|May 1, 1989
Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blastsF Herrmann, A Lindemann, H Klein, et al.
The Journal of Biological Chemistry|October 5, 1990
Control of tetrahydrobiopterin synthesis in T lymphocytes by synergistic action of interferon-gamma and interleukin-2I Ziegler, K Schott, M Lübbert, et al.
British Journal of Haematology|February 23, 1999
Lethal systemic herpes simplex virus type 1 infection during chemotherapy for acute lymphoblastic leukaemiaK Wirth, S Fetscher, D Neumann-Haefelin, et al.
Annals of Hematology|January 1, 1995
Expression of the Fas antigen on primary human leukemia cellsR Munker, M Lübbert, S Yonehara, et al.
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Oncogene|October 26, 2005
ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETOJ Lausen, S Liu, M Fliegauf, et al.
Oncogene|July 8, 2008
Complementing mutations in core binding factor leukemias: from mouse models to clinical applicationsA M S Müller, J Duque, J A Shizuru, et al.
Annals of Hematology|October 8, 2005
An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patientsP W Wijermans, M Lübbert, G Verhoef, et al.
Leukemia & Lymphoma|December 31, 1997
Successful treatment of disseminated central nervous aspergillosis in a patient with acute myeloblastic leukemiaU Mahlknecht, F von Lintig, R Mertelsmann, et al.
Leukemia|July 30, 2003
Absence of somatic mutations within the Runt domain of AML2/RUNX3 in acute myeloid leukaemiaF Otto, M Stock, M Fliegauf, et al.
Leukemia|October 29, 2004
Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanismsK Schmelz, N Sattler, M Wagner, et al.
Leukemia|May 1, 1989
Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blastsF Herrmann, A Lindemann, H Klein, et al.
The Journal of Biological Chemistry|October 5, 1990
Control of tetrahydrobiopterin synthesis in T lymphocytes by synergistic action of interferon-gamma and interleukin-2I Ziegler, K Schott, M Lübbert, et al.
British Journal of Haematology|February 23, 1999
Lethal systemic herpes simplex virus type 1 infection during chemotherapy for acute lymphoblastic leukaemiaK Wirth, S Fetscher, D Neumann-Haefelin, et al.
Annals of Hematology|January 1, 1995
Expression of the Fas antigen on primary human leukemia cellsR Munker, M Lübbert, S Yonehara, et al.
Pageof 12